- Location
IMS Health
"-
Schott Invests in Brazil Packaging Plant
Apr 24, 2015Schott announced that it will continue to invest in its pharmaceutical packaging plant in Itupeva, Brazil on the occasion of its 80th manufacturing anniversary in the country. The company said that it will supply locally-produced ...
-
The Wikipedia Is The Single Leading Source of Medical Information for U.S. Patients
Feb 8, 2014The website Wikipedia is the single leading source of medical information for U.S. patients and healthcare professionals, an information services company says. A report by IMS Health, a global information and technology services company, ...
Tags: Medical Information, Wikipedia
-
ANI Pharmaceuticals Inc. Entered Into a Fee-for-Service Development Agreement
Jan 14, 2014ANI Pharmaceuticals Inc., an emerging generic pharmaceutical company, has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services ("Sterling"). The product will be developed by ...
Tags: ANI Pharmaceuticals Inc, pharmaceutical company, Sterling
-
Mylan Announced That Its U.S. Has Launched Mycophenolic Acid Delayed-Release Tablets
Jan 10, 2014Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic® ...
-
Actavis Plc Has Received Approval From The U.S. FDA on ANDA
Jan 10, 2014Actavis plc (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a ...
-
Show Slower Growth in Health Spending Since The Implementation of The Affordable Care Act
Jan 8, 2014Today, the Centers for Medicare and Medicaid Services (CMS) issued findings that show slower growth in health spending since the implementation of the Affordable Care Act. This successful cost control is consistent with data demonstrating ...
Tags: Centers for Medicare and Medicaid Services, health spending
-
PEDSnet Combines a Clinical Data Research Network
Dec 30, 2013A network of children's hospitals, data partners, and specialty networks led by The Children's Hospital of Philadelphia was recently approved for an award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand ...
-
Actavis PLC Would Prevent Actavis From Commercializing Its Anda Product Prior
Dec 30, 2013Actavis plc (NYSE: ACT) today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and ...
Tags: Actavis, Warner Chilcott Company LLC, Abbreviated New Drug Application
-
Warner Chilcott Has Filed an ANDA with The U.S. FDA Seeking Approval
Dec 30, 2013Today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal ...
-
Mylan Today Announced That Subsidiary Mylan Pharmaceuticals and Partner,Banner Pharmacaps
Dec 19, 2013Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...
Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations
-
Par Pharmaceutical Has Received Final Approval From FDA for Its Anda for Clonidine HCl ER
Oct 10, 2013US-based specialty pharmaceutical firm Par Pharmaceutical has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for clonidine hydrochloride (HCl) extended-release (ER) ...
Tags: Par Pharmaceutical, Medicine
-
California State Assembly Has Passed a Bill
Sep 2, 2013The California State Assembly has passed a bill that restricts generic versions of medicines called biosimilars, upon their launch in the US. Biosimilars are medicines whose active drug substance is derived from living cells. They have ...
Tags: Biosimilar Drugs Bill, Medicine
-
Mylan Has Obtained FDA Approval for sANDA for GSK's WELLBUTRIN XL
Aug 26, 2013Mylan has obtained FDA approval for its supplemental abbreviated new drug application (sANDA) for the generic version of GSK's WELLBUTRIN XL, bupropion hydrochloride extended-release tablets USP (XL), 300mg. Bioequivalence study results ...
Tags: FDA Approval, drug application
-
Dr. Reddy's Laboratories Introduced Divalproex Sodium Extended Release Tablets
Aug 26, 2013Integrated global pharmaceutical company Dr. Reddy's Laboratories has introduced divalproex sodium extended - release tablets, USP, in 250mg and 500mg strengths in the US. The new FDA approved product is the generic version of Depakote ER ...
-
Lupin Pharmaceuticals Gained Tentative FDA Approvals for Armodafinil Tablets
Aug 5, 2013Lupin Pharmaceuticals has gained tentative FDA approvals for Armodafinil tablets, 50mg, 100mg, 150mg, 200mg and 250mg strengths in addition to Doxycycline capsules, 40mg (30mg immediate-release and 10mg delayed-release). Armodafinil ...